Abstract
Cerebellar development occurs mainly postnatally and implies cell proliferation and migration. Hepatocyte growth factor (HGF) and Met are involved in mediating these responses in other tissues and are coexpressed in the cerebellum. Here we show that Met is localized in granule cell precursors and that cultures of these cells respond to HGF with proliferation. To study the role of HGF and Met in the cerebellum in vivo , we produced a viable hypomorphic Met mutant by knocking in the met locus a point mutation to abrogate the receptor Grb2-binding site. A similar mutant was previously described as perinatal lethal. In this “first-generation” knock-in the recombinant locus retained the Neo cassette ( Met grb2/grb2neo+ ). In the knock-in presented here Neo was Loxed and excised by Cre recombinase, which led to higher tissue levels of Met grb2 protein, sufficient to rescue viability. In Met grb2/grb2neo− mice the size of the cerebellum was reduced and foliation defects were evident, especially in the central and posterior half of the vermis . Proliferation of granule precursors in vivo was 25% lower than in controls. In cultures of mutant granule cells HGF-induced microtubule-associated protein kinase activation was reduced and transient. Behavioral tests indicated a balance impairment in Met grb2/grb2neo− mice. Altogether these data indicate that normal cerebellar development and, possibly, function, require HGF and Met, and that proliferation of granule cells in the cerebellum critically depends on full HGF/Met signaling.
References
32
Referenced
72
10.1016/S0896-6273(00)80682-0
10.1016/S0960-9822(99)80195-X
10.1242/dev.126.14.3089
10.1038/5669
10.1016/S0896-6273(00)80938-1
10.1016/S0301-0082(96)00046-9
10.1002/(SICI)1096-9861(19961223)376:4<653::AID-CNE11>3.0.CO;2-N
10.1016/S0165-3806(97)00015-1
10.1002/(SICI)1097-4547(20000215)59:4<489::AID-JNR3>3.0.CO;2-9
10.1038/373699a0
10.1038/376768a0
10.1016/S0092-8674(00)81372-0
10.1038/6310
10.1016/0169-328X(95)00075-4
10.1074/jbc.271.24.14119
10.1038/sj.onc.1200879
10.1074/jbc.271.22.13116
10.1093/nar/23.24.5080
10.1073/pnas.94.4.1488
10.1016/S1097-2765(01)00261-1
10.1016/0092-8674(94)90318-2
10.1002/cne.1052
10.1002/gene.10024
10.1016/0014-5793(95)00578-W
10.1093/oxfordjournals.jbchem.a021283
10.1006/mcne.1999.0803
10.1101/gad.11.24.3341
10.1038/11896
10.1016/0165-3806(96)00492-0
10.1016/S0896-6273(01)00264-1
10.1073/pnas.96.24.14118
10.1038/sj.onc.1203859
Dates
Type | When |
---|---|
Created | 22 years, 9 months ago (Nov. 12, 2002, 1:44 p.m.) |
Deposited | 3 years, 4 months ago (April 13, 2022, 7:49 a.m.) |
Indexed | 2 months, 1 week ago (June 26, 2025, 3:44 a.m.) |
Issued | 22 years, 10 months ago (Oct. 23, 2002) |
Published | 22 years, 10 months ago (Oct. 23, 2002) |
Published Online | 22 years, 10 months ago (Oct. 23, 2002) |
Published Print | 22 years, 9 months ago (Nov. 12, 2002) |
@article{Ieraci_2002, title={Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development}, volume={99}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.222362099}, DOI={10.1073/pnas.222362099}, number={23}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Ieraci, Alessandro and Forni, Paolo E. and Ponzetto, Carola}, year={2002}, month=oct, pages={15200–15205} }